Profile data is unavailable for this security.
About the company
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
- Revenue in USD (TTM)0.00
- Net income in USD-16.03m
- Incorporated1968
- Employees20.00
- LocationPurple Biotech Ltd4 Oppenheimer St., Science ParkREHOVOT 7670104IsraelISR
- Phone+972 39333121
- Fax+972 35097196
- Websitehttps://purple-biotech.com/
More ▼